Quinapril (Aurobindo Pharma Limited)
Welcome to the PulseAid listing for the Quinapril drug offered from Aurobindo Pharma Limited. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Aurobindo Pharma Limited |
| NON-PROPRIETARY NAME: | Quinapril Hydrochloride |
| SUBSTANCE NAME: | QUINAPRIL HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2013-04-29 |
| END MARKETING DATE: | 0000-00-00 |
Quinapril HUMAN PRESCRIPTION DRUG Details:
| Item Description | Quinapril from Aurobindo Pharma Limited |
| LABELER NAME: | Aurobindo Pharma Limited |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 2013-04-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 65862-617_bf3a014a-6b9d-4661-a8fd-38be0cda902d |
| PRODUCT NDC: | 65862-617 |
| APPLICATION NUMBER: | ANDA202725 |
Other QUINAPRIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
